Article info

Download PDFPDF
Extended report
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension

Authors

  1. Correspondence to Dr Jerome Avouac, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France; javouac{at}me.com
View Full Text

Citation

Avouac J, Konstantinova I, Guignabert C, et al
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension

Publication history

  • Received November 13, 2016
  • Revised July 7, 2017
  • Accepted July 18, 2017
  • First published August 11, 2017.
Online issue publication 
January 09, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.